Journal of Neuro-Oncology

, Volume 90, Issue 1, pp 41–46 | Cite as

Malignant prolactinoma with craniospinal metastasis in a 12-year-old boy

  • Abel Po-Hao Huang
  • Shih-Hung Yang
  • Chi-Cheng Yang
  • Meng-Fai Kuo
  • Mu Zon Wu
  • Yong-Kwang Tu
Clinical-Patient Studies


The authors report the clinical features of and imaging studies on a rare case of pediatric malignant prolactinoma. A 12-year-old boy presented with ataxia, blurred vision, and consciousness disturbance. He had received transcranial surgery and adjuvant radiotherapy. However, the tumor regrew with craniospinal metastasis 16 months after the operation. The relevant literature was reviewed regarding the clinical presentation, pathogenesis, treatment approaches, and prognosis of malignant prolactinoma.


Pituitary carcinoma Prolactinoma Pituitary surgery Pediatric neurosurgery 


  1. 1.
    Kaltsas GA, Nomikos P, Kontogeorgos G et al (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089–3099CrossRefPubMedGoogle Scholar
  2. 2.
    Pernicone PJ, Scheithauer BW, Sebo TJ et al (1997) Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804–812CrossRefPubMedGoogle Scholar
  3. 3.
    Partington MD, Davis DH, Laws ER Jr et al (1994) Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 80:209–216CrossRefPubMedGoogle Scholar
  4. 4.
    Kars M, Roelfsema F, Romijn JA et al (2006) Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155:523–534CrossRefPubMedGoogle Scholar
  5. 5.
    Lamas C, Nunez R, Garcia-Uria J et al (2004) Malignant prolactinoma with multiple bone and pulmonary metastases. J Neurosurg (Pediatrics) 101:116–121CrossRefGoogle Scholar
  6. 6.
    Muhr C, Bergstrom M, Lundberg PO et al (1988) Malignant prolactinoma with multiple intracranial metastases studied with positron emission tomography. Neurosurgery 22:374–379CrossRefPubMedGoogle Scholar
  7. 7.
    Sironi M, Cenacchi G, Cozzi L et al (2002) Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report. J Clin Pathol 55:148–151PubMedGoogle Scholar
  8. 8.
    Roncaroli F, Nose V, Scheithauer BW et al (2003) Gonadotropic pituitary carcinoma: HER-2/neu expression and gene amplification. Report of two cases. J Neurosurg 99:402–408CrossRefPubMedGoogle Scholar
  9. 9.
    Thapar K, Kovacs K, Scheithauer BW et al (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99–106CrossRefPubMedGoogle Scholar
  10. 10.
    Zafar MS, Mellinger RC, Chason JL (1984) Cushing’s disease due to pituitary carcinoma. Henry Ford Hosp Med J 32:61–66PubMedGoogle Scholar
  11. 11.
    Zahedi A, Booth GL, Smyth HS et al (2001) Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma. Clin Endocrinol (Oxf) 55:549–556CrossRefGoogle Scholar
  12. 12.
    McCutcheon IE, Pieper DR, Fuller GN et al (2000) Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report. Neurosurgery 46:1233–1239CrossRefPubMedGoogle Scholar
  13. 13.
    Mixson AJ, Friedman TC, Katz DA et al (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529–533CrossRefPubMedGoogle Scholar
  14. 14.
    Adler JR Jr, Gibbs IC, Puataweepong P et al (2006) Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 59:244–254CrossRefPubMedGoogle Scholar
  15. 15.
    Lim S, Shahinian H, Maya MM et al (2006) Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518–520CrossRefPubMedGoogle Scholar
  16. 16.
    Fadul CE, Kominsky AL, Meyer LP et al (2006) Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 105:621–626CrossRefPubMedGoogle Scholar
  17. 17.
    Thapar K, Scheithauer BW, Kovacs K et al (1996) p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765–770CrossRefPubMedGoogle Scholar
  18. 18.
    Lloyd RV, Kovacs K, Young WF Jr et al (2004) Pituitary tumors. In: DeLellis R, Lloyd RV, Heitz PV (eds) Introduction. WHO classification of tumors of the endocrine organs: pathology and genetics of endocrine organs. IARC Press, Lyon, pp 10–13Google Scholar
  19. 19.
    Ragel BT, Couldwell WT (2004) Pituitary carcinoma: a review of the literature. Neurosurg Focus 16:E7CrossRefPubMedGoogle Scholar
  20. 20.
    Nose-Alberti V, Mesquita MI, Martin LC et al (1998) Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 9:53–62CrossRefPubMedGoogle Scholar
  21. 21.
    Roncaroli F, Scheithauer BW, Young WF et al (2003) Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. Am J Surg Pathol 27:477–486CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Abel Po-Hao Huang
    • 1
  • Shih-Hung Yang
    • 1
  • Chi-Cheng Yang
    • 1
    • 2
  • Meng-Fai Kuo
    • 1
  • Mu Zon Wu
    • 3
  • Yong-Kwang Tu
    • 1
  1. 1.Division of Neurosurgery, Department of SurgeryNational Taiwan University Hospital, National Taiwan University College of MedicineTaipeiTaiwan, ROC
  2. 2.Department of PsychologyNational Taiwan UniversityTaipeiTaiwan, ROC
  3. 3.Department of PathologyNational Taiwan University Hospital, National Taiwan University College of MedicineTaipeiTaiwan, ROC

Personalised recommendations